Zeemox CV 625mg Tablet is a combination antibiotic formulation containing Amoxycillin 500mg and Clavulanic Acid 125mg. Amoxycillin is a broad-spectrum penicillin-class antibiotic effective against a wide range of gram-positive and gram-negative bacteria by inhibiting bacterial cell wall synthesis. Clavulanic Acid is a beta-lactamase inhibitor that prevents enzymatic degradation of amoxycillin by beta-lactamase-producing bacteria, thereby extending its spectrum of activity. Zeemox CV 625mg is indicated for the treatment of various bacterial infections including respiratory tract infections (such as sinusitis, bronchitis, and pneumonia), urinary tract infections, skin and soft tissue infections, and otitis media. It is particularly useful in infections caused by beta-lactamase-producing strains resistant to amoxycillin alone. The tablet should be administered orally, preferably at the start of a meal to enhance absorption and reduce gastrointestinal discomfort. Dosage and duration of therapy should be determined by the severity and type of infection, as well as patient-specific factors such as renal function. Common adverse effects may include gastrointestinal disturbances like diarrhea, nausea, and allergic reactions. Use of Zeemox CV 625mg should be guided by susceptibility testing and clinical judgment to minimize resistance development.